dinutuximab
sintilimab
vanucizumab
matuzumab
ozogamicin
panitumumab
antimonoclonal
carlumab
lexatumumab
monoantibody
-mab
inotuzumab ozogamicin
drozitumab
agonistic monoclonal antibody
cibisatamab
-xizu-
polyclonal
bococizumab
immunoglobulin E
hyperimmunoglobulin
sibrotuzumab
oportuzumab monatox
alacizumab
chromobody
atezolizumab
immunoadsorbent
-lim-
durvalumab
lucatumumab
polyantigenic
tabalumab
xenoantibody
multiantigenic
antisubstance
aritox
horseradish peroxidase
dalotuzumab
immunoantigen
nofetumomab
glucoincretin
ABO antibodies
pritumumab
-toxa-
antihuman
brentuximab
faralimomab
seroconversion
heterophil antibody
Forssman antibody
heterophile antibody